Clinical trial
Clinical Course of Patients With Transfusional Hemochromatosis on Deferoxamine
NCT00001203 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Course of Patients With Transfusional Hemochromatosis on Deferoxamine
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 22, 1985
- Completion date
- November 9, 2015
- Enrollment
- 151 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, heart disease, hemochromatosis, thalassemia